ConforMIS is a medical technology company that uses its proprietary iFitÂŽ Image-to-ImplantÂŽ technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patientâs unique anatomy. ConforMIS offers a broad line of customized knee implants designed to restore the natural shape of a patientâs knee. In recent clinical studies, iTotalÂŽ CR, ConforMISâ cruciate-retaining total knee replacement implant and best-selling product, demonstrated superior clinical outcomes, including better function and greater patient satisfaction compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 500 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints and other elements of the iFitÂŽ Image-to-ImplantÂŽ technology platform. ConforMIS believes its iFitÂŽ Image-to-ImplantÂŽ technology platform has application to other major joints in the worldwide market for joint replacement products. Source
No articles found.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates...
Merck KGaA, Darmstadt, Germany, a leading scien...
At BioMarin, we focus on developing first-in-class and best-in-class therapeutics ...
At BioMarin, we focus on developing first-in-cl...
Aptose Biosciences is a clinical-stage biotechnology company developing personaliz...
Aptose Biosciences is a clinical-stage biotechn...
Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and se...
Cancer Genetics, Inc. is an emerging leader in ...
NuVasive is a world leader in minimally invasive, procedurally integrated spine so...
NuVasive is a world leader in minimally invasiv...
Celcuity is a cellular analysis company that is discovering new cancer sub-types a...
Celcuity is a cellular analysis company that is...
STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, de...
STAAR, which has been dedicated solely to ophth...
Join the National Investor Network and get the latest information with your interests in mind.